Stocks · NASDAQ · Healthcare · United States
CGON — CG Oncology, Inc.
CG Oncology, Inc. (CGON) is a healthcare stock listed on NASDAQ (United States). At the close of October 14, 2026 it traded at 61.84 (-0.90% on the day), -16.6% over one month, -13.9% over three months, +44.3% over twelve months. The InvestMuse composite score is -15 on a −100 to +100 scale, a mixed read that ranks #798 of about 1,237 assets. The strongest of its nine dimensions is Technical indicators (+34); the weakest is Regime (hidden Markov model) (-60). Its volatility regime from the hidden Markov model is Cool.
The facts
| Last close | 61.84 (October 14, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -0.90% / -16.6% / -13.9% / +44.3% |
| 52-week range | 37.37 – 80.68 |
| Composite score | -15 / 100 · mixed view · rank #798 |
| Volatility regime (HMM) | Cool |
| Market cap | $6.3B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)-60
- Technical indicators+34
- Trend-22
- Support / resistance0
- Fundamentals0
- Sector edge0
- News sentiment0
- Momentum-28
- Chart patterns and zones-25
More healthcare reads
How this read is made
Every night InvestMuse scores about 1,237 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of October 14, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.